HIV Research and Clinical Trials Services
With nearly two decades of assay development and validation experience in HIV research, Virco develops high-throughput diagnostic solutions for clients to address particular research questions relevant for development of new HIV drugs
- Services offered along the continuum from discovery through clinical trial development
- Large library of HIV viruses containing most of the described mutational patterns and subtypes
- Large genotypic and phenotypic database for advanced queries
- CAP/CLIA validated genotypic and phenotypic assays
Preclinical: HIV
Tap into Virco’s extensive know how, viral databases and viral libraries to gain necessary insights for assisting in the selection and characterization of lead HIV therapeutic candidates.
- Antivirogram® a phenotyping assay using fully replication-competent virus provides invaluable information on the activity of new compounds in comparison to a panel of existing drugs
- Fully customized viral panels including SDM
- Customized plates
- Validation of any new compounds within RT; PROT and INTEGRASE drug classes
- World-class expertise in virology
Clinical Trial Services: HIV
Virco’s HIV clinical trial services are built upon the convergence of our collective strengths:
-
Pioneers in development of HIV resistance assays
- Virco developed the first routine HIV resistance assay used in clinical trials
- Accrual of more than 14 years in providing HIV genotyping and expanded research services to the pharmaceutical industry
- Multiple high profile research collaborations
- The insights and understandings acquired from powerful, unique, genotypic and phenotypic databases
These attributes have allowed Virco scientists to apply their skills and knowledge in the development of world class assays that characterize and track HIV resistance and provide industry support in the clinical development of new HIV compounds.
Virco Clinical Trial Services include:
-
Sequencing assays
- CAP/CLIA validated RT/PROT sequencing assay
- RUO integrase assay(*)
-
Flexible reporting
- Real time reporting
- Special reports
- virco™TYPE HIV-1 interpretation
- Phenotyping:
Please contact us directly so we can help assess your needs and provide additional information on Virco’s offerings for HIV clinical research.
(*) Research use only, not for diagnostic use. The assay is developed for use in/for research activities, may support drug development, and/or data may be submitted to regulatory agencies as supportive scientific data only. Not all performance characteristics of this product have been (fully) established.
